Vertex Pharmaceuticals | 税引前利益

株価
477.92
毎日の変更
19.11 4.17%
毎月
-1.29%
毎年
1.83%
Q1 予測
455.43




税引前利益 変化する 日付
AbbVie USD 4.38B 1.92B 2025-09
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Arrowhead Research USD 28.27M 7.85M 2025-12
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Gilead Sciences USD 2.43B 780M 2025-06
Incyte USD 482.31M 75.7M 2025-09
Insmed USD -368.7M 48.26M 2025-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
J&J USD 4.97B 2.53B 2025-12
Merck USD 6.74B 22M 2025-09
Moderna USD -187M 631M 2025-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Novartis USD 4.2B 335M 2025-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
United Therapeutics USD 438M 29.6M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Vertex Pharmaceuticals 税引前利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.